141.Gritli, S, Khamassi, K, Lachklem, A, et al. Head and neck liposarcomas; a 32 year experience. Auris Nasus Larynx, 2010, 37: 347–351.
142.Enzinger, FM, Weiss, SW. Liposarcoma. Soft tissue tumors. 3rd ed. St. Louis, Mosby-Yearbook Inc., 1995, 431–466.
143.Gollegde, J, Fisher, C, Rhys-Evans, RH. Head and neck liposarcoma. Cancer, 1995, 76: 1051–1058
144.Ozawa, H, Soma, K, Ito, M, et al. Liposarcoma of the retropharyngeal space: report of a case and review of the literature. Auris Nasus Larynx, 2007, 34: 417–421.
145.Marcio, F, Filho, V, Cusino, SR, et al. Periorbital liposarcoma in pediatric patients: a case report. Arg Bras Oftalmul, 2013, 76: 244–246.
146.Zhang, H, Erickson-Johnson, M, Wang, X, et al. Molecular testing of lipomatous tumors: critical analysis and test recommendations based on analysis of 405 extremity based tumors. Am J Surg Pathol, 2010, 34: 1304–1311.
147.Fletcher, CD, Akerman, M, Dalcin, P, et al. Correlation between clinicopathological features and karyotype in lipomatous tumors. A report of 178 cases from the chromosomes and morphology (CHAMP) collaborative study group. Am J Pathol, 1996, 148: 623–630.
148.Knight, JC, Renwick, PJ, Cin, PD, et al. Tranlocation t(12;16) (q.13;p11) in myxoid liposarcoma and round cell liposarcoma. Molecular and cytogenetic analysis. Cancer Res, 1995, 55: 24–27.
149.Antonesu, CR, Tschernyavsky, SJ, Decuseara, R, et al. Prognostic impact of p53 status TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma. A molecular and clinicopathologic study of 82 cases. Clin Cancer Res, 2001, 7: 3977–3987.
150.Hamilton, J, Avitia, S, Osborne, R, et al. Differentiated cervical liposarcoma. Ear Nose Throat J, 2005, 84: 696–706.
151.Hornick, JL, Bosenberg, MW, Michels, JJ, et al. Pleomorphic liposarcoma: clinicopathologic, immunohistochemical, and follow-up analysis of 63 cases. A study from the French Foundation of Cancer Centers Sarcoma Group. Am J Surg Patholo, 2002, 26: 601–616.
152.Ecles, RA, Fisher, C, A’Hern, RP, et al. Head and neck sarcomas prognostic factors and implications for treatment. Br J Cancer, 1993, 68: 201–207.
153.Demetri, GD, Fletcher, CDM, Myeller, E, et al. Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor y PTg and troglitazone in patients with liposarcoma. Proceed Nat Acad of Sci United States of America, 1999, 96: 3951–3956.
154.Mouret, P. Liposarcoma of the hypopharynx. A case report and review of the literature. Rev Laryngol Otol Rhinol, 1999, 120: 39–43.
155.Reitan, JB, Kaalhus, I, Brennhovd, IO, et al. Prognostic factors in liposarcoma. Cancer, 1985, 55: 2482–2490.